New Publications Highlight LifeNet Health's Life Saving Work in Neurosurgery
VIRGINIA BEACH, Va., June 16 /PRNewswire/ -- LifeNet Health, a leading allograft bio-implant and regenerative material company, is pleased to announce two key publications regarding its innovative OsteoCleanse™ autograft cleaning service for the treatment of infected or contaminated cranial bone flaps.
OsteoCleanse™ is one of several advanced technology platforms that LifeNet Health utilizes to help restore health. Thousands of decompressive craniectomies are performed each year, often as the result of traumatic brain injuries (TBIs). Using OsteoCleanse™, the resultant autografts are placed in a custom container, shipped to LifeNet Health, disinfected, labeled, and stored until re-implantation. OsteoCleanse™ is the first process of its kind specifically designed for autologous tissue and is based on LifeNet Health's patented allograft treatment technologies which have been used since 1995 to clean, disinfect, and sterilize allograft tissue to remove risk of disease transmission.
"We are excited that OsteoCleanse™ is receiving national attention in these publications. Through the OsteoCleanse™ autograft cleaning service, LifeNet Health is continuing to advance technology and offer solutions to help restore health and save lives," said Rony Thomas, LifeNet Health CEO and President.
Dr. Scott Graham from the Department of Neurosurgery at the Virginia Commonwealth University pioneered the use of OsteoCleanse™. His first case series is described in "Salvage of contaminated cranial bone flap autografts using OsteoCleanseTM: pilot study case reports" (J. Cell Tissue Bank (2010) 11:155–172). Dr. Gra